A Diagnosis in Demand – The Urgent Need for Post-Acute Infection Syndrome (PAIS) Testing by Dr. Elihu Aranday-Cortes
Discovering Solutions for Long COVID: A T Cell Immunology Breakthrough (feat. Dr. Nigel McCracken)
by Tori Whitacre Martonicz of Infection Control Today
Detecting T Cell Dysfunction in Post-Acute Infection Syndromes (feat. Dr. Nigel McCracken)
by Sophia Abene of Contagion Live
Virax Biolabs Announces Distribution Agreement with Europa Biosite to Commercialize ImmuneSelect in the United Kingdom and Ireland
Virax Biolabs Announces Extension of Existing Exclusive Distribution Agreement to Market Mpox (formerly Monkeypox) Virus RT-PCR Detection Kits with Cosmos Health Inc.
Virax Biolabs Presents at H.C. Wainwright’s 26th Annual Global Investment Conference
Virax Biolabs Announces Distribution Agreement to Commercialize Mpox (formerly Monkeypox) Virus RT-PCR Detection Kits in Europe and the Middle East
Dr. Ailsa Snaith Joins the Virax Biolabs Team
We’re excited to welcome Dr. Ailsa Snaith to the Virax Biolabs team today – she will be the newest member of our Advisory Board. A scientist and clinician with a deep résumé in both academic and non-academic settings, Dr. Snaith will bring years of powerful experience to help us augment our ViraxImmune™ platform. With her recent focus in the role of pathogens in chronic illness and neurodegeneration, she shares our deep passion for our research aims. Read more about her here by visiting her bio.
Measuring the Health of T Cells with Dr. Nigel McCracken
by Talking Biotech Podcast
Jeff Hurwitz and Gordon Powell Join the Virax Biolabs Team
This week, we’re pleased to be welcoming Jeff Hurwitz and Gordon Powell to the team. Their decades of experience in the in-vitro diagnostics (IVD) space will be a great addition to our growing team and will aid us as we expand into new markets. Jeff (Business Development, Americas) will be an agile lead for our market entry in the United States and beyond. For over 25 years, he has spearheaded US sales and commercial strategies for startups and large, global teams alike. Gordon (Advisory Board Member) will utilize his over 30 years of life science expertise to help us take our marketing and commercial strategy to the next level. He is excited to leverage his proven specialization in point-of-care IVDs to augment our business offerings.